RNDr. Jitka Malčíková, Ph.D.
Assistant professor, Šárka Pospíšilová Research Group
Office: bldg. E35/258
Kamenice 753/5
625 00 Brno
Phone: | +420 532 23 4396 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 287
2013
-
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.
Leukemia, year: 2013, volume: 27, edition: 11, DOI
-
Klonální evoluce a selekce mutací TP53 v relapsu chronické lymfocytární leukémie
Year: 2013, type:
-
Molekulární biologie CLL - význam molekulárních prognostických faktorů
Year: 2013, type:
-
Mutace v genu TP53 jsou spojeny s vyšší rezistencí CLL buněk na ofatumumab a rituximab in vitro
Year: 2013, type: Conference abstract
-
Mutační analýza genu NOTCH1 u pacientů s chronickou lymfocytární leukemií
Year: 2013, type: Conference abstract
-
Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life
Year: 2013, type: Conference abstract
-
Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia
Leukemia & Lymphoma, year: 2013, volume: 54, edition: 8, DOI
-
SF3B1 mutations frequently occur with both ATM mutations and TP53 mutations in CLL patients
Year: 2013, type: Conference abstract
-
The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy.
Leukemia & Lymphoma, year: 2013, volume: 54, edition: 9, DOI
-
The expression of a single microRNA -miR-34a - is a reliable marker for impairment of TP53-pathway in chronic lymphocytic leukemia
Year: 2013, type: Conference abstract